A 50-50 chance of success Meanwhile, one of the downsides of popularized GLP-1 drugs is that they have raised people's expectations for rapid weight loss, says Dr
Three GLP-1 agonists are approved to treat type 2 diabetes
When you have a peptide from a different species, you may not have the peptidase, the hormone that degrades it, Andrew Young, former vice president of research at Byetta producer Amylin Pharmaceuticals, explained in our feature
Currently, dental complications are not recognized as part of ongoing Ozempic-related legal claims
If patients are on GLP-1s long enough that delayed emptying doesnt continue to that degree, its mostly the hyperglycemia control and/or insulin use. Schulman also said, More research is needed to determine whether length of usage or dosing frequency alters an individuals procedural risk
This is a normal and expected response to weight loss, not a side effect of the medication itself